Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of October 2020, with a specific transaction date of October 28, 2020. The document serves as a transaction notification regarding share allocations for Non-Executive Directors under the company's share allocation arrangements for the service period of July 1, 2020, to September 30, 2020.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details specific equity transactions involving the following instruments and prices:
- Ordinary Shares (GBP): Priced at £13.50 per share.
- American Depositary Shares (ADSs) (USD): Priced at $35.29 per ADS.
Material Changes
The filing reports no material changes to the company's financial position or operations. It documents the acquisition of notional shares by eight Non-Executive Directors as compensation for their service. These are routine equity-based compensation events and do not represent a change in the company's strategic direction or financial health compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document is a statutory disclosure of director share transactions required under securities regulations.
Important Facts for Investors
- Transaction Type: All reported transactions are acquisitions of notional shares/ADSs by Non-Executive Directors, not open market purchases or sales by insiders.
- Participants: Transactions were executed for Sir Jonathan Symonds, Mr. Charles Bancroft, Mr. Vindi Banga, Dr. Vivienne Cox, Ms. Lynn Elsenhans, Dr. Laurie Glimcher, Dr. Jesse Goodman, Ms. Judy Lewent, and Mr. Urs Rohner.
- Service Period: The allocations correspond to the period of service from July 1, 2020, to September 30, 2020.
- Volume Details:
- Sir Jonathan Symonds acquired 3,240.741 Ordinary Shares.
- Mr. Charles Bancroft acquired 866.616 ADSs.
- Mr. Vindi Banga acquired 671.296 Ordinary Shares.
- Dr. Vivienne Cox acquired 625.000 Ordinary Shares.
- Ms. Lynn Elsenhans acquired 615.753 ADSs.
- Dr. Laurie Glimcher acquired 1,140.284 ADSs.
- Dr. Jesse Goodman acquired 376.294 ADSs.
- Ms. Judy Lewent acquired 399.099 ADSs.
- Mr. Urs Rohner acquired 625.000 Ordinary Shares.